How Complement and FcRn Inhibitors Are Changing gMG Treatment

bir ses eklendi Health

2025-06-18 11:40:05

Generalized Myasthenia Gravis (gMG) is a chronic, autoimmune neuromuscular disorder characterized by fluctuating skeletal muscle weakness. Driven by autoantibodies that impair neuromuscular transmission, gMG affects voluntary muscles involved in eye movement, swallowing, breathing, and limb activity. Advances in immunology and biologics have shifted the therapeutic landscape from broad...

0 Yorumlar 0 hisse senetleri 57 Views 0 önizleme